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holesterolemiand (2) the elevated thrombin generation in these patients is
abolished by treatment with pravastatin.
D96485 Serum Lipoprotein(a) level is Related to ThrombinGeneration and Coronary Patency during Acute
Myocardial Infarction
A.W. Haider, F. Andreotti 1,A. Mas6ri G.J. Davies. RPMS, Harnrnerarnith
Hospita/, London, UK, 1Lstitufodi Cardio/ogia, Catholic University Rome,
Italy
occlusion of the infarct related coronary artery is often intermittent in the
early, evolving phase of acute myocardial infarction. To assess their relation-
ship to this pattern of coronary occlusion, serum or plasma concentrations of
cholesterol, triglyceride, lipoprotein(a) and coagulation and fibrinolytic factors
wera measured in venous blood before the initiation of thrombolyfic therapy.
Thirty two patients (23 men, 9 women, age 30-70 years) with acute my-
ooardial infarction”received i.v rt-PA (20-60 MU) within 6 hours of the onset
of symptoms. Continuous ECG ST segment recording demonstrated inter-
mittent occlusion of the infarct related coronary artery in 12 patients (group
1) before the start of thrombolytic treatment, and persistent occlusion in 20
patients (group 2). Groups 1 and 2 were similar in age, gender, race, dura-
tion of symptoms, bloat sample collection time, location of the infarct related
coronary artery and extent of coronary,atiery disease. The serum level (me-
dian ~nterquartile range]) of lipoprotein(a) was 34 (13-47) mg/dLversus 11.5
(5-27) mg/dL (P= O.02)and the plasma level (median [interquartile range]) of
thrombin-antithrombin Ill complex was 10.85 (6.4-21.5) versus 6,8 (4.2-6.7)
vg.L-l (p < 0.04) in groups 1 and 2, respectively. Lipoprotein(a) values >30
mg/dL were found in 60% of patients in group 1 and 13% of those in group
2 (p < 0.001). These findings demonstrate different modes of evolution of
coronary thrombosis related to lipoprotein(a) and thrombin levels. The latter
may be of pathogenetic significance and closely related to the mechanism
that determines the rate of progression of infarction.
D96486 Aortic Cholesterol Content in LDL-ReceptorDeficiency Rabbita Correlate With Vaacular
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Detectable Change h Vhro
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Previously, we showed that early atherosclerosis in LDL-receptor deficient
rabbits (LDL[-]), undetectable by angiography, and minimal by intravascular
ultrasound (IVUS) and histology, is associated with marked changes in exvivo
reaidual strain. To further identify sensitive indices of early atherosclerosis,
we studied: (1) the in vivo aorfic compliance, as assessed by IVUS and
blood pressure measurements; (2) the ex vivo residual strain; and (3) aortic
cholesterol content in 11control and 11 LDL[–] rabbits.
Com@iancs(mm21kPa)Residualstrain(%) Aoriiccholesterol(&g/mg)
Control 1.85* 1.20 5.2+0.02 1.8* 0.5
LDL[-] 0.77+0.47” 1s.0+ &4* 16+ 12*
*p <0.01 vs.oontrols.
The residual strain and aorfic cholesterol content were highly inversely
correlated in the ascending (r= -0.72, p = 0.001), descending thoracic (r=
-0.94, p c 0.001), and abdominal aorta (r = –0.61, p = 0.004). However,
IVUS-detarmined aorticcompliance correlated neither with the residual strain
nor the aortic cholesterol content. We corrch.fdathat the earliest stages of
athercgenesis are associated with substantial alterations in the biomachani-
CSIpropetiies of the vessel. These findings underscore the need to develop
more senaitive methoda to detect and quantitete early changes in vascular
compliance in viw.
D96487 Impaired Lipolyaia of Very Low DenaityLlpoproteine In Type Ill Hyperlipoproteinemia
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Mutatione in the APOE gene are associated with type Ill hyperlipoproteine-
mia (HLP) and premature coronary artery disease (CAD). The severity of the
HLP correlates with the binding to heparan sulphate proteoglycans (HSPG),
illustrating the importance of HSPG as bridging glycoprotein in recaptor-
mediated clearance. In addition, HSPG anchor lipoprotein Iipase (LPL) to the
endothelium. We hypothesize that VLDL from patients with apoE mutations
show diminished interaction with HSPG, and, as a consequence, impaired
Iipolysis by HSPG-bound LPL, In order to test this hypothesis, in vitro binding
and Iipolysis experiments were performed with VLDL, isolated from E3E3
controls (n = 6), hyperlipidemic apoE2 (Arglsa + Cys) (n =4) and hyperlipi-
demicheterozygous carriers of the APOE*3-Leiden @=4)allele. The binding
of VLDL isolated from apoE2 (Arg’56 -+ Cys) and APOE3-Leiden carriers
to HSPG-LPL was reduced to 47% and 40%, respectively (p < 0.05). The
Iipolysis rates were 77.5% and 76.7%, respectively, of that of control VLDL (p
<’0.05). Thus, a binding impairment of VLDL was paralleled by a defective
Iipolysis, which may contribute to the increased risk for CAD in patients with
type Ill HLP.
m Modulatio.ofLDL~afiic,e~iZeA*eran~ al
Glttcoae Load is Associated With Inaulin Releaae
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People with a predominance of small LDL particles appear to be at increased
risk for corona~ artery disease regardless of the presence of other risk fac-
tors. The LDL phenotypes can be modulated by environmental factors. The
purpose of this study was to determine whether the LDL particle size is mod-
ulated in response to a 75-g oral glucose load in 40 subjects. The size of the
LDLparticle was determined bytheuseof nondenaturing polyac@amide gm-
dient gel electrophoresis. The LDL peak size was significantly and inversely
correlated with apoE, apoB, remnant-like particles-cholesterol, triglyceride,
glucose, IRI, BMI, and blood pressure ievels in the fasting state. In response
to a 75-g oral glucose load, 17 of 40 subjects presented the plasma glucoae
levels z140 mg/dl after 2 hours. The difference in LDL particle size (ALDL
size) between the fasting and2-hr postprandial state was inversely correlated
with the fasting LDL particle size (ALDL size = 26.84113 x !asting size;
r = 0.421, p = 0.008), indicating that the LDL larger than 254A decreased
in size after glucose load and that the LDL smaller than 254 ~ increased
in size. Also, ALDL size was positively correlated with BMI and logarithms
of post-load glucose levels. Forward stepwise regression analysis selected
these three parameters as independent factors capable of influencing LDL
particle size (R2 = 0.496); post-load plasma glucose levels, BMI, and total
IRI levels. This indicates that the IRI level is an independent contributor to
determine the change in the size of LDL particle after adjustment for BMI
and glucose levels. These results suggest that the degree of insulin release
during glucose load is a determinant for the decrease in LDL particle size.
m Effects of OxYgen Radicalaon Human Lipoprotein
— (a) and Low Denaity Lipoprotein Peroxidation and
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Human lipoprotein (a) (Lp (a) is considered a risk factor for corona~ artery
disease. Oxidation of LDL may play a pivotal role in athercgenesis. The
first aim was to compare the effects of pathophysiological amount of oxygen
radicals on Lp (a) and LDL, induced by xanthine (2 mM) + xanthine oxidase
(85 mU/ml), or by human polymorphonuclear leukocytes in the presence of
2 mM phorbol-12-myristate-13-acetate. Results, with both oxidants, showed
that Lp (a) was peroxidized earlier than LDL (conjugated dienes, lag time)
although both the final amount of lipid peroxidative stable “metabolizes(lipid
peroxides, MDA)and protein oxidation degree (positive charged amino acids,
apo B fragmentation) were similar. Thus, the relatively higher susceptibility
to peroxidation may render Lp (a) particularly susceptible to modification
induced by pathophysiological concmtration of oxygen radicals in vitro. This
phenomenon may contribute to atherogenic properties of Lp (a), and could
have relevant clinical sequelae in those patients with high levels of cirou-
Iating Lp (a). To further investigate the metabolic removal of lipid peroxides
in vivo, we used a rat experimental model. Infusion in the porlal vein of
Wistsr rats (n = 6.for each group) of either oxidized LDL or Lp (a) but not
native Iipoproteinastimulated activation mainly of hepatic Kupffer cells (paeu-
dopodes and microvacuoles) observed by electronic microscope. In contrast,
both native LDL and Lp (a) did not induce hepatic cell activation. Moreover,
the monoclinal antibodies MDAZ (directed against MDA-lyaine epitopes of
oxidized lipoproteins and proteins) and NA59 (against 4-hydroxynonenal-
Iysines) have recognized such “oxidation specific” epitopes in hepatic rat
tissues. There are no significant degree of monoclinal antibcdy remgnition
between oxidized forms of LDL and Lp (a).
Our study shows that: 1) Lp (a) is peroxidized earlier than LDL, and 2)
